Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Hester Biosciences has informed that the Company has scheduled investor interaction through a teleconference call on Friday, 10 May 2024 at 2:00 pm (IST), post the announcement of financial results for the quarter and year ended 31st March 2024. Details for joining the call are attached.
The above information is a part of company’s filings submitted to BSE.